DNA testing in familial hypertrophic cardiomyopathy: clinical and laboratory implications.

@article{Smart1996DNATI,
  title={DNA testing in familial hypertrophic cardiomyopathy: clinical and laboratory implications.},
  author={Robin Smart and Bing Yu and Huong Le and Julie A French and David R. Richmond and Richmond W. Jeremy and Christopher Semsarian and Linda W Cheung and David A. Ross and Ronald J. A. Trent},
  journal={Clinical genetics},
  year={1996},
  volume={50 4},
  pages={169-75}
}
Counselling and clinical assessment in familial hypertrophic cardiomyopathy (FHC) is difficult, particularly in the young, since echocardiographic and ECG changes may not be diagnostic and clinical severity can vary. From 1990, when the beta-cardiac myosin heavy chain gene was implicated in the aetiology of FHC, considerable information about the molecular… CONTINUE READING